Dr. John Patrick McLaughlin, DO

Dr. McLaughlin practices at Harrisburg Endoscopy and Surgery Center in Harrisburg, Pennsylvania.

Dr. McLaughlin's NPI, 1609854157, was assigned on January 5, 2006. Dr. McLaughlin graduated from Philadelphia College of Osteopathic Medicine in 1973. Dr. McLaughlin holds Pennsylvania license OS003871L.

Dr. McLaughlin's primary practice is Harrisburg Endoscopy and Surgery Center, at 4760 Union Deposit Road, Harrisburg, PA 17111. The practice phone is (717) 545-8525.

Dr. McLaughlin's primary practice is Harrisburg Endoscopy and Surgery Center in Harrisburg, Pennsylvania. Dr. McLaughlin is also affiliated with UPMC Harrisburg. The medical group on file is Harrisburg Gastroenterology. Dmand AI also links Dr. McLaughlin to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. McLaughlin is licensed in Pennsylvania.

CMS data shows 1,313 Medicare services from Dr. McLaughlin across 21 procedure codes in 2024, for 617 Medicare patients. Medicare paid $123,570 for them.

CMS counts 617 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 65 to 74, with 287 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 64, with 55% women.

In 2024, Dr. McLaughlin wrote 2,609 Medicare Part D claims for 584 patients. 89% of them were for generic drugs. CMS names the drug for 2,404 of them, across 37 drugs with 11 or more claims each, at $331,258 in total drug cost. In 2023, CMS named 1,811 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. McLaughlin for performance year 2024, reported as part of a group. Dr. McLaughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 189 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. McLaughlin, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. McLaughlin, published from 2020 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Arthroplasty, Replacement, Hip, Osteoarthritis, Hip and Patient Reported Outcome Measures. Dr. McLaughlin has published most often in J Arthroplasty. Dr. McLaughlin's most frequent co-authors are Nicolas Santiago Piuzzi, MD, Matthew E. Deren, MD and Trevor G. Murray, MD.

Dmand AI links Dr. McLaughlin to 1 clinical trial. Conditions studied include Infections.

CMS Open Payments shows 753 general payments to Dr. McLaughlin from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $3,483.

Dr. McLaughlin graduated from Philadelphia College of Osteopathic Medicine in 1973.